The abnormalities in the small airways contribute to the symptoms of asthma. The small airways dysfunction may be attributed to many factors; mainly inflammation, remodeling, and changes in the surrounding tissue. Small airways affection associates with worse control of asthma, more frequent exacerbations, presence of nocturnal symptoms, more severe bronchial hyper-responsiveness, exercise-induced asthmatic symptoms, and the late-phase allergic response. Forced oscillation technique (FOT) was found to have higher sensitivity to inhaled corticosteroid (ICS) or to β-agonist inhalation than spirometry. Both ICS and β-agonists improve small-airway function, and FOT responses manifest eminent changes in indices of peripheral airway obstruction. In contrast, spirometric sensitivity to small-airway function is less eminent. Accordingly, it is expected that FOT might provide useful indices of peripheral airway change in response to therapeutic interventions. Aim The aim of this study was to evaluate the effect of regular use of ICS on small-airway function of asthmatic patients using impulse oscillometry (IOS).
Introduction
Bronchial asthma is characterized by chronic airway inflammation. It can be diagnosed by the history of respiratory symptoms such as wheezing, dyspnea, chest discomfort, and cough. These symptoms may be variable over time and in intensity, and also there is variable expiratory airflow limitation [1] .
The diagnosis of asthma depends on history of recurrent respiratory signs and symptoms consistent with asthma, together with the objective demonstration of airflow limitation. Variability in airflow obstruction means that the obstruction is not necessarily present at all times; it changes with time, exposure to triggering stimuli, and medications. A good response to treatment in a patient with previous history of asthma supports the diagnosis. However, objective confirmation of the variability in airflow limitation characterizing asthma, using spirometry or peak expiratory flow monitoring, is sometimes mandatory, especially if response of patients to treatment is below the required level or if symptoms are not typical of asthma [2] .
Systemic corticosteroids are used in the treatment of acute asthma exacerbations in the emergency room (ER) and have been proven to be effective and are included in different asthma guidelines like Global Initiative for Asthma (GINA) and Expert Panel Report 3 [3] .
Spirometry is used for measuring lung functions by evaluating the volume of exhaled air after maximum inhalation. The parameters obtained from this forceful exhaled maneuver are the most accurate indications to diagnose COPD. These obtained values of these parameters are compared with predicted normal values. These preset values depend on the age, height, sex, and ethnicity. These parameters were the cornerstone in many COPD guidelines that categorize the disease into mild, moderate, and severe levels [4] .
On the contrary, impulse oscillometry (IOS) is an easy, noninvasive method demanding only tidal breathing, and it allows measuring lung function through evaluating both airway resistance and airway reactance [5] .
Patients and methods
This was a prospective study carried out at Kobry El-Qobba Military Chest Hospital, Cairo, Egypt. A total of 30 patients newly diagnosed as having bronchial asthma according to GINA guidelines, 2015 parameters, in the outpatient clinic and inpatient department were included in the study through the period from July 2015 to December 2015.
Exclusion criteria
The following were the exclusion criteria:
(1) Inability to perform IOS.
(2) Concomitant chronic respiratory disease.
All patients were subjected to the following:
(1) Detailed history taking and clinical examination.
(2) Radiological assessment by plain chest radiographic posteroanterior view and computed tomography chest to exclude any other chronic chest disease.
(3) Spirometric lung functions were obtained using the Cardiotouch 3000 Bionet (BiTech Medical Corp., Atlanta, USA), and a full report was obtained including forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), FEV 1 /FVC, and maximum mid-expiratory flow (MMEF) 25-75. (4) IOS was performed using commercially available IOS unit (Jaeger GmbH, Hoechberg, Germany), and a full report was obtained including airway resistance at 5 Hz (R5) and 20 Hz (R20), as well as reactance at 5 Hz (X5) before the recommended treatment, and then after 1 month and 3 months.
Spirometry
The Cardiotouch 3000 Bionet was used. Patient's age, sex, and height were recorded and entered into the spirometer so that predicted curves and values can be calculated by the spirometer.
It is mandatory to explain the purpose of the test and describe the steps carefully. Sometimes, it was useful to simulate the procedure and highlight the importance of taking a full inspiration and that expiration should be as fast and hard as possible.
Impulse oscillometry
The Jaeger MasterScreen Impulse Oscillometry System (Jaeger GmbH) provided with reference values was used ( Fig. 1 ). Impedance was defined as the spectral ratio between the amplitude of the pressure wave signal and the resulting flow signal. From its values, airway resistance at 5 and 20 Hz (R5rs and R20rs) and reactance at 5 Hz (X5rs) were automatically calculated. The test was performed according to the manufacturer's instructions and the guidelines of the ERS Task Force 2003 [6] .
Figure 1
The Jaeger Master Screen Impulse Oscillometry System.
The patients were asked to sit upright during the procedure, put on a nose clip, and support their cheeks with both hands as a kind of support. They pursed their lips firmly around the mouthpiece, and positioned the tongue below the level of the mouthpiece to avoid artifacts ( Fig. 2 ). Recording of the measured values should start after 30 s of regular tidal breathing. Each patient should fulfill an optimum of three maneuvers free of artifacts (i.e. resistance at 10 Hz within 10% of highest obtained value). Measurement from the three efforts for each of the IOS parameters was then averaged for final results.
Spirometry and IOS were performed in the first visit (day 1) and then the patients were maintained on the recommended inhaled corticosteroid (ICS) treatment, and the dosages were adjusted.
Patients were classified into mild, moderate, and severe persistent asthma and then ICS dose adjustment was done according to the GINA 2015 guidelines.
Then patients were recruited at 1 month and then 3 months intervals to repeat the spirometry and the IOS, and the results were monitored and recorded.
Results
The total number of cases was 30 patients. The mean of age was 23.60±3.05 years (range: 19-29 years) and were divided to eight (26.7%) males and 22 (73.3%) females.
Asthma severity among the studied patients was mild in four (13.3%) cases and moderate in 26 (86.7%) cases (Tables 1-7) .
Discussion
Small airways constitute a small percentage of the total respiratory resistance so there may be extensive damage of small airways before the patient shows symptoms, and this why they are called the 'silent zone' of airways. Moreover, the peripheral location of the small airways and their small diameter make them very difficult to be directly assessed. Thus, they are usually evaluated indirectly, through evaluating the effects of their partial occlusion, such as premature closure, air trapping, heterogeneous ventilation, and lung volume dependence of airflow limitation [7] .
IOS is different from conventional pulmonary functions in its ability to be used for both children and adults and also to evaluate obstruction in both large and small peripheral airways. It has been used to measure reversibility and to perform bronchoprovocation testing. IOS may be also beneficial in predicting poor control in asthmatic children [8] .
The present study aimed at assessing the effect of regular use of ICS on small-airway function of newly diagnosed asthmatic patients using IOS. To fulfill this aim, 30 patients newly diagnosed as having bronchial asthma Subject performing impulse oscillometry. Effect of inhaled corticosteroids on small airways in asthmatics using impulse oscillometry Elbouhy et al. 217 and 3 months intervals correspondingly of regular recommended ICS treatment.
In the current study, there was a high significant improvement regarding FEV 1 , FVC, FEV 1 /FVC, and MMEF 25-75 at 1 month and 3 months of regular recommended treatment. Our results come in accordance with the results of Klaustermeyer [9] , who studied corticosteroids-dependent asthmatic patients over a period of 10 months to set up a baseline for future therapeutic trials with corticosteroids-sparing medications. FEV 1 and FVC were recorded at outpatient clinic, and they showed statistically significant improvement.
Our results also came in accordance with those of Lange et al. [10] , who studied 234 patients with asthma and treatment with ICS over 10-year followup. The decrease in FEV 1 in the 44 patients treated with ICS was 25 ml/year compared with 51 ml/year in the 190 patients not treated with ICS and came to conclusion that treatment with ICS is associated with a significantly reduced decline in ventilatory function.
In the current study, there was highly statistically significant improvement regarding change in FEV 1 , FVC, FEV 1 /FVC, and MMEF 25-75 when comparing 1 day, 1 month, and 3 months. Regular use provides progressive improvement over time, and these results match with those of Yamaguchi et al. [11] , who believed that small airways play a primary role in asthma. IOS can examine the resistance of total (R5), large (R20), and small airways (R5-R20) separately, and low-frequency reactance area (AX) is also considered a measure of small airways dysfunction. Mild-to-moderate asthmatics who received ICS were arranged randomly into 26 patients who received 200 μg hydrofluoroalkane-134a beclomethasone dipropionate bid and 12 patients who received 400 μg chlorofluorocarbon dipropionate bid for 12 weeks. IOS and spirometry were done as the baseline then were repeated every 4 weeks, and methacholine challenge was done to assess airway sensitivity and airway reactivity separately and lung volumes at 12 weeks. They came to a conclusion that hydrofluoroalkane-134a beclomethasone dipropionate is an effective treatment of small airways in asthma. Prolonged treatment gives a progressively gradual improvement over time, which is associated with a decline of airway responsiveness.
In the current study, there was a significant improvement regarding the R5, R20, and X5 at 1 month and 3 months of regular recommended treatment. This matched the study done by Yamaguchi et al. [11] , who studied 38 mild-tomoderate asthmatic patients who received ICS for 12 weeks. IOS and spirometry were repeated every 4 weeks, and the highly statistically significant improvement started to appear just after 4 weeks.
In the current study, there was statistically significant improvement regarding the R5, R20, and X5 at 3 months of regular recommended treatment. Although Saadeh et al. [12] studied 30 patients with mild-to-moderate chronic obstructive pulmonary disease, their results were in accordance to ours. All their patients were monitored by IOS, followed by spirometry. Lung function was measured at baseline and then after administration of ICS for 3 months. All IOS parameters showed significant improvement, with a 39% decrease in impedance, 31% decrease in overall airway resistance, and 15% decrease in resistance in the larger airways (R15). They concluded that IOS parameters showed higher sensitivity compared with spirometry for monitoring reversibility of airway obstruction and the effect of maintenance therapy. IOS may enhance early treatment, optimization of the dose, and personalization of medications for patients with chronic obstructive pulmonary disease.
In the current study, both spirometric and IOS parameters were equally sensitive in detecting reversibility of airways obstruction. These results matched those of Manoharan et al. [13] , who studied 442 asthmatic physicians who had both IOS and spirometry measurements and were linked to a health information database for oral steroid and short acting beta-2 agonist (SABA) use 1 year prior to these index measurements. They found that spirometry or IOS measurements were equally useful as potential indices of asthma control in persistent asthmatic patients.
Nieto et al. [14] studied respiratory function in 23 children with mild asthma, and a positive bronchodilator response was evaluated by spirometry and oscillometry. Oral montelukast was administered for 4 weeks, and they were again evaluated. As a control group, 23 similar patients receiving no preventive therapy underwent the same study. They found that children on oral montelukast showed improvements in all oscillometry parameters, and montelukast improved both central and especially peripheral airways function in the first month of treatment, as evaluated by IOS. These findings come in accordance with our results that stated that regular use of ICS as a preventive treatment is reflected as an improvement in both spirometric and IOS parameters equally.
In the current study, we found a highly significant improvement regarding change in R5, R20, and X5 at 1 day, 1 month, and 3 months. This fully matched with Yamaguchi et al. [11] , who stated that prolonged treatment offers a progressively gradual improvement over time, which is accompanied with a decline of airway hyper-responsiveness.
A complicated concept, respiratory reactance (Xrs) reflects lung elastic recoil properties. Low-frequency Xrs is associated with peripheral airway obstruction. At lower frequencies, there is passive lung distension, enhanced lung compliance, decreased elastic recoil pressure, and decreased Xrs [15] . Thus, Xrs improvement is an indirect indicator of small airways improvement. This was proved in the current study, where there was progressive significant statistical improvement of the small airways function as measured with reactance (Xrs), both at 1 and 3 months of regular use of recommended ICS dose. The participation of the peripheral small airways may be judged by the difference between R5 and R20, and therefore can help to understand small airways pathology. However, the anatomical position of the transition between the small and large airways has not been established. Yet, there is proof that lowfrequency resistance and reactance measurements correlate well with transpulmonary resistance measured by esophageal manometry and other conventional small airways measures [16] .
In the current study, although there was an improvement regarding the peripheral resistance (PR) as there were 23 patients showing positive high PR at day 1; this number decreased to 21 patients after 1 month of regular recommended ICS treatment, and then only 16 patients were left with positive high PR after 3 months of regular recommended ICS treatment, yet we found no statistically significant difference regarding the PR after 1 month and 3 months, respectively. May be larger number of patients or longer periods of follow-up were needed to achieve the statistical significance.
Conclusion
From the current study, we can conclude that using IOS is equally sensitive as spirometry in diagnosis and follow-up of adult asthmatic patients. Small-airway involvement in the pathogenesis of asthma will no longer be missed, as it can be measured either qualitatively as the presence or absence of high PR values or quantitatively through measuring the reactance (Xrs). The more the patient is adherent to his or her daily recommended dose of ICS, the more evident is the improvement in his or her IOS and spirometric parameters, including parameters that measure the small airways affection starting from the very first few weeks of proper treatment.
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